Who May Be a Good Candidate for IV Therapy
Neuropeptide levels in Alzheimers disease and dementia with frontotemporal degeneration
In preclinical research, this peptide has shown promising potential in supporting tissue regeneration, angiogenesis (new blood vessel formation), and cellular signaling related to healing
Was the route the same as the commercial product
It is based on a naturally occurring peptide from the pineal gland, a neuroendocrine organ involved in circadian rhythm and hormone regulation
and Howard Weiss, Vice President, Federal Programs, America's Health Insurance Plans Staff from CMS's Center for Medicare (Linda Anders, Kathryn Coleman, Martha Hennessey, Wanda Pigatt-Canty, Erica Sontag, Scott Sturiale, Tim Roe, Nishamarie Sherry) and Medicare-Medicaid Coordination Office (Vanessa Duran, Paul Precht, Marla Rothouse) Jim Verdier, Senior Fellow, Mathematica Policy Research, Inc